APA (7th ed.) Citation

CH, H., SI, W., FS, F., HJ, L., & JC, W. (2026). Association of PCSK9 inhibitors versus statins with cancer incidence: A target trial emulation. Cardio-oncology (London, England), 12(1), 19. https://doi.org/10.1186/s40959-025-00436-0

Chicago Style (17th ed.) Citation

CH, Huang, Wang SI, Fan FS, Lu HJ, and Wei JC. "Association of PCSK9 Inhibitors Versus Statins with Cancer Incidence: A Target Trial Emulation." Cardio-oncology (London, England) 12, no. 1 (2026): 19. https://doi.org/10.1186/s40959-025-00436-0.

MLA (9th ed.) Citation

CH, Huang, et al. "Association of PCSK9 Inhibitors Versus Statins with Cancer Incidence: A Target Trial Emulation." Cardio-oncology (London, England), vol. 12, no. 1, 2026, p. 19, https://doi.org/10.1186/s40959-025-00436-0.